| 2种用药方案治疗社区获得性肺炎的成本-效果分析 |
| |
| 引用本文： | 张玉娥,韦超霞. 2种用药方案治疗社区获得性肺炎的成本-效果分析[J]. 中国药房, 2008, 19(8): 566-568 |
| |
| 作者姓名： | 张玉娥 韦超霞 |
| |
| 作者单位： | 1. 广东江门市五邑中医院/暨南大学医学院第六附属医院临床药学室,江门市,529000
2. 桂林医学院,桂林市,541004 |
| |
| 摘 要： | 目的:探讨2种药物治疗方案对社区获得性肺炎的经济效果。方法:采用回顾性研究方法,选择88例社区获得性肺炎患者,分别给予头孢哌酮钠/舒巴坦钠组(A组)、左氧氟沙星组(B组),观察2组疗效并进行成本-效果分析。结果:A组与B组成本分别为1803·91、1599·81元(P>0·05),有效率分别为95·0%、100·0%(P>0·05),成本-效果比分别为1898·85、1599·81。结论:B组方案优于A组方案。
|
| 关 键 词： | 社区获得性肺炎 头孢哌酮/舒巴坦钠 左氧氟沙星 成本-效果分析 |
| 文章编号： | 1001-0408(2008)08-0566-03 |
| 修稿时间： | 2007-04-19 |
Cost-Effectiveness Analysis of Cefoperazone Sodium/Sulbactam Sodium vs.Levofloxacin in the Treatment of Community Acquired Pneumonia |
| |
| ZHANG Yu-e,WEI Chao-xia. Cost-Effectiveness Analysis of Cefoperazone Sodium/Sulbactam Sodium vs.Levofloxacin in the Treatment of Community Acquired Pneumonia[J]. China Pharmacy, 2008, 19(8): 566-568 |
| |
| Authors: | ZHANG Yu-e WEI Chao-xia |
| |
| Affiliation: | ZHANG Yu-e, WEI Chao-xia (1 Dept. of Clinical Pharmacy, Guangdong Jiangmen Municipal Wuyi Hospital of TCM＆The Sixth Affiliated Hospital of Medical College of Ji＇nan University, Jiangmen 529000, China; 2 Guilin Medical College, Guilin 541004, China) |
| |
| Abstract: | OBJECTIVE： To evaluate the cost- effectiveness of two therapeutic schemes in the treatment of community acquired pneumonia. METHODS： A retrospective study was conducted in which a total of 88 cases with community acquired pneumonia were randomly assigned to receive cefoperazone sodium/sulbactam sodium （Group A） or levofloxacin （Group B） . The therapeutic effects were monitored and the cost - effectiveness analyses were conducted on the two group. RESULTS： The cost was 1 803.91 yuan in Group A versus 1 599.81 yuan in Group B （P 〉 0.05）; the effective rates were 95.0% versus 100.0% （P 〉0.05） and the cost -effectiveness ratios were 1 898.85 and 1 599.81, respectively. CONCLUSION： Levoflocaxin is superior to cefoperazone sodium/sulbactam sodium for community acquired pneumonia. |
| |
| Keywords: | Community acquired pneumonia Cefoperazone sodium/sulbactam sodium Levofloxacin Cost effectiveness analysis |
| 本文献已被 维普 万方数据 等数据库收录！ |
